Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples